We are thrilled to announce the launch of Myhibbin, the new FDA-approved liquid form of the immunosuppressant mycophenolate mofetil, expertly renamed by WANT Branding! Azurity Pharmaceuticals hired WANT to develop this innovative name, resulting in the clever fusion of “Mycophenolate” and “Inhibit.” The name Myhibbin not only reflects its active ingredient but also its critical […] The post Brand New! The U.S. FDA has approved Myhibbin™, the only ready-to-use mycophenolate mofetil...
